Cite
HARVARD Citation
Scholz, A. et al. (2016). Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma. EMBO molecular medicine. 8 (1), pp. 39-57. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Scholz, A. et al. (2016). Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma. EMBO molecular medicine. 8 (1), pp. 39-57. [Online].